Cell Symposia: Cancer Epigenomicss

Confirmed Speakers

Peter J. Tummino

Peter J. Tummino

Dr. Tummino received his Ph.D. from the Department of Biological Chemistry, University of Michigan in 1992.  After completing a postdoctoral fellowship at Warner-Lambert/Parke-Davis, Dr. Tummino held positions of increasing responsibility at Warner-Lambert/Parke-Davis, AstraZeneca, and Millennium Pharmaceuticals. 

He joined GlaxoSmithKline in 2003, was previously Director of the Department of Enzymology and Mechanistic Pharmacology, and is now Head of Biology & Translational Medicine for the Cancer Epigenetics Discovery Performance Unit in Oncology R&D.  Dr. Tummino has worked in anti-infective, metabolic disease, and oncology preclinical drug discovery.  The focus of his research has been the identification, characterization, and progression of enzyme inhibitors as novel therapeutics.

« Go Back


Premium Sponsors

Sponsor-Seahorse Bioscience

Sponsor-Thermo Scientific

Sponsor

Abcam
Active Motif
The Baker Company
PerkinElmer
Rockland
TOCRIS
TransOMIC

Twitter

Supporting Publications-Cancer Cell

Supporting Publications

Supporting Publications - Cancer Cell

Supporting Publications - Molecular Cell

Supporting Publications - Cell

Twitter

Supporting Publications-Cancer Cell